Comparison of nitroprusside and nitroglycerin in inhibition of angiotensin II and other vasoconstrictor-mediated contraction in human coronary bypass conduits

British Journal of Clinical Pharmacology

Volumn 44, Issue 4, 1997, Pages 361-367

  He, Guo Wei ^a   Yang, Cheng Qin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin II; Endothelin 1; Internal mammary artery; Nitroglycerin; Nitroprusside

Indexed keywords

ANGIOTENSIN; ENDOTHELIN 1; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; VASODILATATION;

EID: 0030866003     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.t01-2-00589.x     Document Type: Article

References (28)

1. Hahn AWA, Resink TJ, Kern F, Buhler F. Peptide vasoconstrictors, vessel structure, and vascular smooth-muscle proliferation. J Cardiovasc Pharmacol 1993; 22(Suppl 5): S37-S43.
2. Oliver JA, Sciacca RR. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984; 74: 1247-1251.
3. Dzau VJ, Safar MI. Large conduit arteries in hypertension: role of the vascular renin angiotensin system. Circulation 1988; 77: 947-954.
4. He G-W, Yang C-Q, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary surgery. Ann Thorac Surg 1995; 59: 676-683.
5. He G-W, Yang C-Q. Comparison among arterial grafts and coronary artery. An attempt at functional classification. J Thorac Cardiovasc Surg 1995; 109: 707-715.
6. Kawasuji M, Tedoriya T, Takemura H, Sakakibara N, Taki J, Watanabe Y. Flow capacities of arterial grafts for coronary artery bypass grafting. Ann Thorac Surg 1993; 56: 957-962.
7. Loop FD, Thomas JD. Hypoperfusion after arterial bypass grafting. Ann Thorac Surg 1993; 56: 812-813.
8. Taylor KM, Bain WH, Russel M, Brannan JJ, Morton IJ. Peripheral vascular resistance and angiotensin II levels during pulsatile cardiopulmonary bypass. Thorax 1979; 34: 594-598.
9. Cooper TJ, Clutton-Brock TH, Jones SN, Tinker J, Treasure T. Factors relating to the development of hypertension after cardiopulmonary bypass. Br Heart J 1985; 54: 91-95.
10. Van Zwienen JCW, Van der Linden CJ, Cimbrere JSF, Lacquet LK, Booij LHDJ, Hendriks T. Endothelin release during coronary artery bypass grafting (Abstract). Chest 1993; 103: 176s.
11. Barker JE, Anderson J, Treasure T, Piper PJ. Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin II. Br J Clin Pharmacol 1994; 38: 57-62.
12. 1-adrenoceptor mediated contraction in the human internal mammary artery. J Cardiovasc Pharmacol 1993; 21: 256-263.
13. ACC/AHA. Guidelines for the early management of patients with acute myocardial infarction. Circulation 1990; 82: 667.
14. He G-W, Angus JA, Rosenfeldt FL. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: Relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol 1988; 12: 12-22.
15. He G-W, Buxton B, Rosenfeldt F, Angus JA. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. Circulation 1989; 80(Suppl): I-141-I-150.
16. He G-W, Yang C-Q, Mack MJ, Acuff TE, Ryan WH, Starr A. Interaction between endothelin and vasodilators in the human internal mammary artery. Br J Clin Pharmacol 1994; 38: 505-512.
17. He G-W, Shaw J, Yang C-Q, et al. Inhibitory effects of glyceryl trinitrate on α-adrenoceptor mediated contraction in the internal mammary artery. Br J Clin Pharmacol 1992; 34: 236-243.
18. 2+-activated K channels in regulation of mesangial contraction by nitroprusside and ANP. Am J Physiol 1996; 270: C1773-C1779.
19. Wei JY, Reid PR. Quantitative determination of nitroglycerin in human plasma. Circulation 1979; 59: 588-592.
20. Yap PSK, McNiff EF, Fung H-L. Improved GLC determination of plasma nitroglycerin concentrations. J Pharm Sci 1978; 67: 582-584.
21. Maurice DH, Crankshaw D, Haslam RJ. Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur J Pharmacol 1991; 192: 235-242.
22. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann Rev Pharmacol Toxicol 1985; 25: 593.
23. Murphy RA. Contraction in smooth muscle cells. Ann Rev Physiol 1989; 51: 275.
24. Dillon PF, Aksoy MO, Driska SP, Murphy RA. Myosin phosphorylation and the cross-bridge cycle in arterial smooth muscle. Science 1981; 211: 495.
25. Hai CM, Murphy RA. Cross-bridge phosphorylation and regulation of latch state in smooth muscle. Am J Physiol 1988; 254: C99.
26. Sakanashi M, Matsuzaki T, Aniya Y. Nitroglycerin relaxes coronary artery of the pig with no change in glutathione content or glutathione S-transferase activity. Br J Pharmacol 1991; 103: 1905-1908.
27. Muruhara T, Kugiyama K, Yasue H. Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide. J Vasc Res 1996; 33: 78-85.
28. Matsumoto T, Takahashi M, Nakae I, Kinoshita M. Vasorelaxing effect of S-Nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin. J Pharmacol Exp Ther 1995; 275: 1247-1253.